388870 Stock Chart & Stats
₩5390.00
₩490.00(10.00%)
―
--
Day’s Range― - ―
52-Week Range₩3,710.00 - ₩12,120.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)88.97K
Market Cap
₩61.30B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.18
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding12,945,932
10 Day Avg. Volume62,270
30 Day Avg. Volume88,974
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2,613,803.23
Revenue Forecast (FY)₩80.91T
388870 FAQ
What was Pharos iBio Co., Ltd.’s price range in the past 12 months?
Pharos iBio Co., Ltd. lowest stock price was ₩3710.00 and its highest was ₩12120.00 in the past 12 months.
What is Pharos iBio Co., Ltd.’s market cap?
Pharos iBio Co., Ltd.’s market cap is ₩61.30B.
When is Pharos iBio Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pharos iBio Co., Ltd.’s earnings last quarter?
Pharos iBio Co., Ltd. released its earnings results on May 14, 2026. The company reported -₩170.91 earnings per share for the quarter, missing the consensus estimate of N/A by -₩170.91.
Is Pharos iBio Co., Ltd. overvalued?
According to Wall Street analysts Pharos iBio Co., Ltd.’s price is currently Undervalued.
Does Pharos iBio Co., Ltd. pay dividends?
Pharos iBio Co., Ltd. does not currently pay dividends.
What is Pharos iBio Co., Ltd.’s EPS estimate?
Pharos iBio Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharos iBio Co., Ltd. have?
Pharos iBio Co., Ltd. has 12,945,932 shares outstanding.
What happened to Pharos iBio Co., Ltd.’s price movement after its last earnings report?
Pharos iBio Co., Ltd. reported an EPS of -₩170.91 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.465%.
Which hedge fund is a major shareholder of Pharos iBio Co., Ltd.?
Currently, no hedge funds are holding shares in KR:388870
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
iNtRON Biotechnology, Inc.
―
CytoGen, Inc.
―
PanGen Biotech, Inc.
―
KoBioLabs, Inc.
―
ENCell Co., Ltd.
―